CRSP Short Interest
CRISPR Therapeutics AG
1W: +3.2%
1M: -4.8%
3M: +8.0%
YTD: -4.3%
1Y: -23.9%
3Y: +33.3%
5Y: -48.7%
$51.47
+2.46 (+5.02%)
Pre-Market: $51.38 (-0.09, -0.18%)
Weekly Expected Move ±6.6%
$43
$46
$49
$53
$56
Credit Risk of going bust: lower than 50% of companies Debt: 13.6% of company value Bonds: none of note held by US funds details ▾
If the stock fell to about $0.70 (down 99%), CRISPR Therapeutics AG would be worth roughly what it owes.
Total debt $783.7M against a stock market value of $4.98B.
Distance to default 5.14 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $293.1M (short-term plus half of long-term), stock volatility 57.2%; Altman Z'' 3.71. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Total debt $783.7M against a stock market value of $4.98B.
Distance to default 5.14 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $293.1M (short-term plus half of long-term), stock volatility 57.2%; Altman Z'' 3.71. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Short Volume Summary
2026-10-2664.4%
Short Ratio
of total volume
60.2%
20-Day Avg
59.3%
50-Day Avg
▲ Rising
5-Day Trend
0.3M
Short Volume
0.5M
Total Volume
Daily Short Volume Ratio
Short Volume vs Total Volume
Exchange Breakdown
2026-10-26| Exchange | Short Volume | Total Volume | Short % |
|---|---|---|---|
| NASDAQ | 322,468 | 499,000 | 64.6% |
| NYSE | 20,256 | 30,309 | 66.8% |
| BATS | 1,081 | 4,690 | 23.1% |